Uncategorized
Enrollment complete in Allegro’s phase 2b trial of Luminate
The last patient has been enrolled in Allegro Ophthalmics’ phase 2b trial of Luminate for patients with diabetic macular edema, according to a company press release.Luminate (ALG-1001) will be studied in 120 patients in the double masked, placebo-controlled, 6-month DEL MAR trial.